Prosecution Insights
Last updated: November 18, 2026

Cybin Irl Limited

Technology area: Biotechnology & Pharmaceuticals

6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Cybin Irl Limited has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 6 distinct examiners and 6 distinct art units, showing that each pending matter follows its own recorded examination path.

SAEED, KAMAL A is the busiest examiner, with 1 pending matter. Since the examiner and art-unit assignments are fully distributed, counsel should focus on the individual claim issues and prosecution histories rather than seek efficiencies from a shared examination setting.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (17%)
4
Medium (67%)
0
Easy (0%)
1
Unknown (17%)

Rejection Statute Mix

BucketCases
§103 only3 (50%)
Double-patenting + other1 (17%)
Multi-statute (no §101)1 (17%)
No statute on record1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
83% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
17% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SAEED, KAMAL A 1 83.9% +9.8%
VALENROD, YEVGENY 1 72.6% +25.0%
LEE, SIN J 1 68.7% +25.2%
ABDALHAMEED, MANAHIL MIRGHANI ALI 1 50.3% +39.1%
LUAN, SCOTT 1 65.6% +11.6%
MCDOWELL, BRIAN E 1 74.0% +31.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18707825 FORMULATIONS OF PSILOCYBIN ANALOGS AND METHODS OF USE VALENROD, YEVGENY —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18561152 FORMULATIONS OF PSILOCYBIN MCDOWELL, BRIAN E 72d
18707825 FORMULATIONS OF PSILOCYBIN ANALOGS AND METHODS OF USE VALENROD, YEVGENY —
18688125 COMBINATION DRUG THERAPIES LEE, SIN J —
18588132 METHODS OF TREATING DISORDERS WITH A PSILOCYBIN ANALOG ABDALHAMEED, MANAHIL MIRGHANI ALI —
18576487 INTEGRATED DATA COLLECTION DEVICES FOR USE IN VARIOUS THERAPEUTIC AND WELLNESS APPLICATIONS LUAN, SCOTT —

Top Art Units

Art UnitApps
1626 1
1628 1
1613 1
1622 1
3792 1
1624 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18883262 DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE SAEED, KAMAL A 1626 Other Non-Final OA — Pending Sep 12, 2024
18707825 FORMULATIONS OF PSILOCYBIN ANALOGS AND METHODS OF USE VALENROD, YEVGENY 1628 §103§112 Non-Final OA — Pending May 06, 2024
18688125 COMBINATION DRUG THERAPIES LEE, SIN J 1613 §103DP Final Rejection — Pending Feb 29, 2024
18588132 METHODS OF TREATING DISORDERS WITH A PSILOCYBIN ANALOG ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 §103Other Non-Final OA — Pending Feb 27, 2024
18576487 INTEGRATED DATA COLLECTION DEVICES FOR USE IN VARIOUS THERAPEUTIC AND WELLNESS APPLICATIONS LUAN, SCOTT 3792 §103 Non-Final OA — Pending Jan 04, 2024
18561152 FORMULATIONS OF PSILOCYBIN MCDOWELL, BRIAN E 1624 §103Other Final Rejection 72d Pending Nov 15, 2023

Managing Cybin Irl Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Cybin Irl Limited have?

Cybin Irl Limited has 6 pending office actions as of November 2026, spread across 6 art units and 6 examiners.

Which USPTO examiner handles the most Cybin Irl Limited applications?

Kamal A Saeed has the most, with 1 of Cybin Irl Limited's pending office actions.

What technology area are Cybin Irl Limited's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month